ImStem Biotechnology, Inc. Makes Progress on Multiple Sclerosis Treatment with Embryonic Stem Cells

FARMINGTON, Conn., June 5, 2014 /PRNewswire/ — ImStem Biotechnology, Inc. (ImStem) announced today it has successfully treated an animal model of multiple sclerosis (MS) using human embryonic stem cells (hESC) derived mesenchymal stem cells (MSCs), called hES-MSCs. Photo – http://photos.prnewswire.com/prnh/20140605/94816 Photo – http://photos.prnewswire.com/prnh/20140605/94808 MS is a chronic neuroinflammatory disease with no cure. Most current MS […]